MDXG FY 2019 Earnings — MiMedx Group, Inc. Revenue & Financial Results | Market Cap Arena

MDXGMiMedx Group, Inc.

$666M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$299M-16.7% YoY

Gross Profit

$256M85.6% margin

Operating Income

-$21M-7.1% margin

Net Income

-$26M-8.5% margin

EPS (Diluted)

$-0.24

Cash Flow

Operating Cash Flow

-$39M

Free Cash Flow

-$42M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$167M

Total Liabilities

$133M

Stockholders' Equity

$34M

Cash & Equivalents

$69M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$299M	$359M	-16.7%
Gross Profit	$256M	$323M	-20.6%
Operating Income	-$21M	-$4M	-439.2%
Net Income	-$26M	-$30M	+14.7%